United States · FDA National Drug Code directory

BRIELLYN

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 68462-316_6eb1e9bd-c526-4036-b9b4-ac88811d76e2
Product NDC: 68462-316
Form: KIT
Composition / generic term: Norethindrone and Ethinyl Estradiol
Labeler: Glenmark Pharmaceuticals Inc., USA
Marketing category: ANDA
Marketing start / end (source format): 20110323
Source listing expiry: 20271231

Source-listed ingredients

Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.

These values do not establish equivalence or a dose recommendation.

Packages

3 BLISTER PACK in 1 CARTON (68462-316-29) / 1 KIT in 1 BLISTER PACK · 68462-316-29

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →